[1]Rweyemamu M, Roeder P, MacKay D, et al. Planning for the progressive control of footandmouth disease worldwide[J]. Transbound Emerg Dis, 2008, 55(1):7387.
[2]卫生部.手足口病预防控制指南(2008年版)[J].热带病与寄生虫学,2008,6(2):122.
[3]国家卫生部办公厅,国家中医药管理局办公室.中医药防治手足口病临床技术指南[S].200941.
[4]孙传兴.临床疾病诊断依据治愈好转标准[M].2版.北京:人民军医出版社, 1998:172.
[5]Komatsu H, Shimizu Y, Takeuchi Y, et al. Outbreak of severe neurologic involvement associated with Enterovirus 71 infection[J]. Pediatr Neurol, 1999, 20(1): 1723.
[6]Ho M, Chen ER, Hsu KH, et al. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group[J]. N Engl J Med, 1999, 341(13): 929935.
[7]张凡.手足口病的中医辨证施治[J].四川中医,2004,22(1):1517.
[1]丁剑波,张佳莹,田一梅,等.喜炎平注射液治疗手足口病的Meta分析[J].环球中医药,2013,6(08):585.
DING Jian bo,ZHANG Jia ying,TIAN Yi mei,et al.Metaanalysis of Xiyanping injection in the treatment of handfootmouth disease[J].,2013,6(05):585.
[2]马羽萍,郭雅玲,康立,等.手足口病1155例中医临床特征分析[J].环球中医药,2012,5(03):206.
[3]杨华升,杨薇,李娜,等.体质从化理论在诊治手足口病中的应用[J].环球中医药,2012,5(04):247.
YANG Hua sheng,YANG Wei,LI Na,et al.Developmental changes and ending depend on constitution of handfoodmouth disease(HFMD) patients[J].,2012,5(05):247.
[4]李静,周红瀛.喜炎平联合α-干扰素治疗小儿手足口病普通型104例[J].环球中医药,2012,5(04):301.
[5]潘艳伶,盖国忠.中医药治疗手足口病临床研究概述[J].环球中医药,2012,5(06):477.
PAN Yan ling,GAI Guo zhong..Review on the clinical research of traditional Chinese medicine on the treatment of handfootmouth disease[J].,2012,5(05):477.
[6]张伟,林连升,王融冰,等.手足口病并发中枢神经系统感染327例中医证候及核心病机分析[J].环球中医药,2012,5(07):512.
ZHANG Wei,Lin Lian-sheng,Wang Rong-bing,et al.TCM syndromes and etiology-pathogenesis in 327 cases of hand-foot-mouth disease with central nervous system infections[J].,2012,5(05):512.
[7]卢红蓉,杜松.手足口病中医病因病机认识有关问题探讨[J].环球中医药,2012,5(11):823.
[8]洪可,聂凡,聂广,等.手足口病2024例病因病机和分期辨证研究[J].环球中医药,2012,5(05):332.
HONG Ke,NIE Fan,NIE Guang,et al.Etiology and mechanism and syndromes differenation in periods on 2024 HFMD patients[J].,2012,5(05):332.